Filtering by:
Breast Cancer in MenStudy Finds Antioxidants Risky During Breast Cancer Chemotherapy
Taking certain supplements while undergoing chemotherapy for breast cancer may do more harm than good. A small study found that patients who took antioxidants had higher chances of cancer recurrence and death.
FDA Approves First PI3K Inhibitor for Breast Cancer
The US Food and Drug Administration (FDA) has approved the first treatment of its kind for a certain type of breast cancer caused by an inherited genetic mutation. Piqray (alpelisib) is a targeted therapy called a PI3K inhibitor.
FDA Approves Consumer Test for Certain BRCA Mutations
The US Food and Drug Administration (FDA) has approved the first direct-to-consumer tests for certain BRCA1 and BRCA2 gene mutations.
FDA Approves First Drug Specifically for BRCA-mutated Breast Cancer
The US Food and Drug Administration (FDA) has for the first time approved a treatment specifically for a type of breast cancer caused by a mutated BRCA gene: Lynparza (olaparib).
Cancer Facts and Figures: Death Rate Down 25% Since 1991
The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society.